dkk 1,255.50 <%= Resources.Global.txtUp %>
Updated 15:59:57
Change % 2.78% Stock price increasing
Change 34.00 Stock price increasing
Volume 152,347
High DKK 1,255.50
Low DKK 1,216.50
Open DKK 1,230.00
ISIN DK0010272202
Prev close DKK 1,221.50
# of shares 61.25M
Market cap 76,901M DKK
Intraday

Market closed
Genmab A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,255.50 -0.9% Stock price decreasing -1.9% Stock price decreasing 10.9% Stock price increasing -3.2% Stock price decreasing -8.4% Stock price decreasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

News about Genmab A/S

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 54,06 2.7% Stock price increasing 6.6% Stock price increasing 17.0% Stock price increasing 15.6% Stock price increasing 13.5% Stock price increasing 12.2% Stock price increasing
 
Bristol-Myers Squibb Company 52,04 1.7% Stock price increasing -16.6% Stock price decreasing -19.0% Stock price decreasing -13.2% Stock price decreasing -6.5% Stock price decreasing -15.1% Stock price decreasing
 
Johnson & Johnson 128,01 1.1% Stock price increasing 0.6% Stock price increasing -11.9% Stock price decreasing -9.7% Stock price decreasing 3.5% Stock price increasing -8.4% Stock price decreasing
 
Pfizer Inc 36,85 0.6% Stock price increasing 5.3% Stock price increasing -5.5% Stock price decreasing 3.5% Stock price increasing 8.8% Stock price increasing 1.7% Stock price increasing
 
Amgen Inc 175,37 2.2% Stock price increasing 2.5% Stock price increasing -10.5% Stock price decreasing 0.1% Stock price increasing 7.8% Stock price increasing 0.8% Stock price increasing
 
Bavarian Nordic A/S 170.50 0.5% Stock price increasing -9.2% Stock price decreasing -28.3% Stock price decreasing -34.8% Stock price decreasing -53.7% Stock price decreasing -24.0% Stock price decreasing
 
Merck Kgaa O.N. 81,70 -0.4% Stock price decreasing 7.4% Stock price increasing -9.5% Stock price decreasing -11.0% Stock price decreasing -24.1% Stock price decreasing -9.0% Stock price decreasing
 
Novartis NAM SF 0,50 63,56 -0.1% Stock price decreasing -1.5% Stock price decreasing -15.9% Stock price decreasing -9.1% Stock price decreasing -10.7% Stock price decreasing -10.0% Stock price decreasing
 
Roche Hldg AG GEN 183,48 1.5% Stock price increasing 0.1% Stock price increasing -8.0% Stock price decreasing -7.6% Stock price decreasing -23.5% Stock price decreasing -12.8% Stock price decreasing
 
Biogen Inc 273,86 4.1% Stock price increasing 3.3% Stock price increasing -25.6% Stock price decreasing -11.0% Stock price decreasing -1.0% Stock price decreasing -14.0% Stock price decreasing
 
Emergent Biosolutions Inc 52,20 -3.8% Stock price decreasing -1.8% Stock price decreasing 2.8% Stock price increasing 28.6% Stock price increasing 72.2% Stock price increasing 12.3% Stock price increasing
 
Bayer AG NA O.N. 97,34 -1.7% Stock price decreasing 7.2% Stock price increasing -9.1% Stock price decreasing -12.9% Stock price decreasing -13.6% Stock price decreasing -6.4% Stock price decreasing
Indices Open
 
OMX Copenhagen 20 CAP 1,115.19 0.3% Stock price increasing 0.7% Stock price increasing -3.0% Stock price decreasing -6.2% Stock price decreasing -0.8% Stock price decreasing -2.5% Stock price decreasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 Cap 1,115.19 1.1% Stock price increasing
12,13,30,42,56,60,61,83,87,95
Instruments Last Change  
Eisai CO Ltd 54,06 -1.2% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Bristol-Myer.. 52,04 0.5% Stock price increasing
Johnson & Jo.. 128,01 1.0% Stock price increasing
Pfizer Inc 36,85 0.5% Stock price increasing
Amgen Inc 175,37 0.3% Stock price increasing
61,44,13,8,49,63,67,93,88,73
Bavarian Nor.. 170.50 6.2% Stock price increasing
6,31,42,30,31,43,60,79,85,89
Merck Kgaa O.. 81,70 1.0% Stock price increasing
Novartis NAM.. 63,56 1.5% Stock price increasing
Roche Hldg A.. 183,48 0.0% Stock price decreasing
Biogen Inc 273,86 1.6% Stock price increasing
0,62,38,36,38,26,77,75,51,30
Emergent Bio.. 52,20 -0.2% Stock price decreasing
Bayer AG NA .. 97,34 -0.1% Stock price decreasing

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/JPM: Sætter kursmålet op med 145 kr. til 1215 kr.
JPMorgan
1,215 op
24/04/18
Genmab/Barclays: Dækning indledes med
Barclays
1,475
01/03/18
Genmab/Carnegie: Kursmålet sænkes til 1210 kr. fra 1392 kr.
Carnegie
1,210
19/12/17
Genmab/ABG: Sænker kursmål til 1430 kr. men gentager
ABG Sundal Collier
1,430 ned
18/12/17
Genmab/Jyske: Kursmålet trimmes til 1600 kr. - NY
Jyske Bank
1,600
15/12/17
Genmab/Jyske: Kursmålet trimmes til 1600 kr.
Jyske Bank
1,600
15/12/17
Genmab/Citi: Kursmålet bliver løftet til 1800 kr. - citat
Citigroup
1,800 op
01/06/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 April 2018 23:58:51
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180423.5 - EUROWEB6 - 2018-04-27 00:58:51 - 2018-04-26 23:58:51 - 1000 - Website: OKAY